Philip P. Boudreau
CIK: 0001805099
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ABBOTT LABORATORIES
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Sep 1, 2026ABT
ABBOTT LABORATORIES
Tax Payment(F)Direct388 shares at avg. $110.36$43K - Apr 23, 2026ABT
ABBOTT LABORATORIES
Purchase(P)Indirect2.2K shares at avg. $91.50$201K - Apr 23, 2026ABT
ABBOTT LABORATORIES
Discretionary(I)Indirect8.9K shares at avg. $92.04$820K - Feb 27, 2026ABT
ABBOTT LABORATORIES
Tax Payment(F)Direct7.4K shares at avg. $116.26$865K - Feb 24, 2026ABT
ABBOTT LABORATORIES
Award(A)Direct28K shares- - Sep 1, 2025ABT
ABBOTT LABORATORIES
Tax Payment(F)Direct387 shares at avg. $132.66$51K - Aug 8, 2025ABT
ABBOTT LABORATORIES
Sale(S)Direct5.6K shares at avg. $134.55$747K - Feb 28, 2025ABT
ABBOTT LABORATORIES
Tax Payment(F)Direct4.9K shares at avg. $135.87$667K - Feb 25, 2025ABT
ABBOTT LABORATORIES
Award(A)Direct22.5K shares- - Sep 1, 2024ABT
ABBOTT LABORATORIES
Tax Payment(F)Direct387 shares at avg. $113.27$44K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 1, 2026 | ABT ABBOTT LABORATORIES | Tax Payment(F) | 388 | $110.36 | $42,820 | Direct |
| Apr 23, 2026 | ABT ABBOTT LABORATORIES | Purchase(P) | 2,200 | $91.50 | $201,300 | Indirect |
| Apr 23, 2026 | ABT ABBOTT LABORATORIES | Discretionary(I) | 8,909 | $92.04 | $819,984 | Indirect |
| Feb 27, 2026 | ABT ABBOTT LABORATORIES | Tax Payment(F) | 7,441 | $116.26 | $865,091 | Direct |
| Feb 24, 2026 | ABT ABBOTT LABORATORIES | Award(A) | 27,997 | - | $0 | Direct |
| Sep 1, 2025 | ABT ABBOTT LABORATORIES | Tax Payment(F) | 387 | $132.66 | $51,339 | Direct |
| Aug 8, 2025 | ABT ABBOTT LABORATORIES | Sale(S) | 5,550 | $134.55 | $746,758 | Direct |
| Feb 28, 2025 | ABT ABBOTT LABORATORIES | Tax Payment(F) | 4,908 | $135.87 | $666,850 | Direct |
| Feb 25, 2025 | ABT ABBOTT LABORATORIES | Award(A) | 22,495 | - | - | Direct |
| Sep 1, 2024 | ABT ABBOTT LABORATORIES | Tax Payment(F) | 387 | $113.27 | $43,835 | Direct |
1-10 of 10 transactions
About Boudreau Philip P
Boudreau Philip P (SEC CIK 0001805099) files insider reports with the SEC as EVP AND CFO of ABBOTT LABORATORIES (ABT).
Signal8 holds 9 ownership filings by Boudreau Philip P, all Form 4s, filed between Sep 4, 2024 and Sep 3, 2026. Those filings report 10 transactions, from Sep 1, 2024 to Sep 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Boudreau Philip P's filings is in ABBOTT PARK, IL.
Recent filings by Boudreau Philip P
- Sep 1, 2026: Tax withholding of ABT shares (Form 4, code F).
- Apr 23, 2026: Open-market purchase of ABT shares (Form 4, code P).
- Apr 23, 2026: Discretionary transaction transaction of ABT shares (Form 4, code I).
- Feb 27, 2026: Tax withholding of ABT shares (Form 4, code F).
- Feb 24, 2026: Grant or award of ABT shares (Form 4, code A).
Other insiders filing for ABBOTT LABORATORIES (ABT)
- Stratton John G, Director
- Gonzalez Patricia Paola, Director
- Conroy Kevin T, Director
- Ahuja Nita, Director
- Roman Michael F, Director
- MCCOY JOHN A. JR., VICE PRESIDENT AND CONTROLLER